European journal of endocrinology · 2026
Integrated clinical-genetic-pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kuhn Aliny Weber, Lerario Antonio Marcondes, Charchar Helaine Laiz, Mariani Beatriz Marinho de Paula, Vaduva Patricia, Nishi Mirian Yumie, Ledesma Felipe Lourenco, Srougi Victor, Chambô José Luis, Mendonca Berenice B, Latronico Ana Claudia, Bertherat Jérôme, Almeida Madson Q, Fragoso Maria Candida Barisson Villares
Аннотация
CONTEXT: Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of ACTH-independent Cushing syndrome (CS), occurring in isolation or as part of Carney complex (CNC); its phenotypic and molecular spectra remain incompletely defined.
OBJECTIVE: To characterize phenotypic variability, genotype-phenotype correlations, and molecular findings in PPNAD through integrated clinical, histopathological, and genetic analyses.
METHODS: We evaluated 18 index patients with PPNAD (15 with CNC, 3 isolated) and performed cascade genetic screening in relatives (20 variants-positive). Clinical, hormonal, imaging and histopathological data were reviewed; germline and somatic analyses employed targeted next-generation sequencing and copy-number assessment.
RESULTS: Overt CS was present in 83% of index cases; 17% had cyclic hypercortisolism. Pathogenic or likely-pathogenic germline PRKAR1A variants were identified in 70.6% probands, including four novel variants; germline PRKACA duplications were detected in two cases. Cascade screening identified eight asymptomatic variant-positive relatives, in whom mild autonomous cortisol secretion (MACS) was observed. Somatic second-hit alterations in tumor tissue included PRKACA duplication, a PRKAR1A frameshift deletion, and 17q24.2 loss of heterozygosity. Histology most often showed classic PPNAD but also nonclassical patterns, expanding the morphological spectrum. Extra-adrenal manifestations were frequent (lentigines 61%, cardiac myxomas 22%).
CONCLUSION: In this referral cohort, PPNAD/CNC displays marked phenotypic variability, incomplete penetrance with subclinical cortisol excess, and diverse molecular mechanisms, including novel germline variants and somatic second hits. Some cases lacked identifiable drivers, suggesting additional uncharacterized mechanisms. Systematic genetic screening and recognition of MACS are important for early diagnosis and long-term management.
OBJECTIVE: To characterize phenotypic variability, genotype-phenotype correlations, and molecular findings in PPNAD through integrated clinical, histopathological, and genetic analyses.
METHODS: We evaluated 18 index patients with PPNAD (15 with CNC, 3 isolated) and performed cascade genetic screening in relatives (20 variants-positive). Clinical, hormonal, imaging and histopathological data were reviewed; germline and somatic analyses employed targeted next-generation sequencing and copy-number assessment.
RESULTS: Overt CS was present in 83% of index cases; 17% had cyclic hypercortisolism. Pathogenic or likely-pathogenic germline PRKAR1A variants were identified in 70.6% probands, including four novel variants; germline PRKACA duplications were detected in two cases. Cascade screening identified eight asymptomatic variant-positive relatives, in whom mild autonomous cortisol secretion (MACS) was observed. Somatic second-hit alterations in tumor tissue included PRKACA duplication, a PRKAR1A frameshift deletion, and 17q24.2 loss of heterozygosity. Histology most often showed classic PPNAD but also nonclassical patterns, expanding the morphological spectrum. Extra-adrenal manifestations were frequent (lentigines 61%, cardiac myxomas 22%).
CONCLUSION: In this referral cohort, PPNAD/CNC displays marked phenotypic variability, incomplete penetrance with subclinical cortisol excess, and diverse molecular mechanisms, including novel germline variants and somatic second hits. Some cases lacked identifiable drivers, suggesting additional uncharacterized mechanisms. Systematic genetic screening and recognition of MACS are important for early diagnosis and long-term management.